| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6847699
[patent_doc_number] => 20030166866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin'
[patent_app_type] => new
[patent_app_number] => 10/058907
[patent_app_country] => US
[patent_app_date] => 2002-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 36036
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058907 | Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin | Jan 27, 2002 | Abandoned |
Array
(
[id] => 7397325
[patent_doc_number] => 20040038889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Fumaric acid amides'
[patent_app_type] => new
[patent_app_number] => 10/433295
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2864
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433295
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433295 | Fumaric acid amides | Jan 7, 2002 | Issued |
Array
(
[id] => 111902
[patent_doc_number] => 07718613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Armed peptides'
[patent_app_type] => utility
[patent_app_number] => 10/250641
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 9948
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250641 | Armed peptides | Jan 3, 2002 | Issued |
Array
(
[id] => 642190
[patent_doc_number] => 07122628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Process for the synthesis of a peptide having a Trp residue'
[patent_app_type] => utility
[patent_app_number] => 10/451486
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4043
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122628.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451486 | Process for the synthesis of a peptide having a Trp residue | Dec 18, 2001 | Issued |
Array
(
[id] => 6552453
[patent_doc_number] => 20020111311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Daptomycin and related analogs in crystalline form'
[patent_app_type] => new
[patent_app_number] => 10/024405
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5760
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024405 | Daptomycin and related analogs in crystalline form | Dec 17, 2001 | Abandoned |
Array
(
[id] => 6751157
[patent_doc_number] => 20030045678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods for preparing purified lipopeptides'
[patent_app_type] => new
[patent_app_number] => 10/023517
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16241
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023517 | Methods for preparing purified lipopeptides | Dec 16, 2001 | Abandoned |
Array
(
[id] => 6750963
[patent_doc_number] => 20030045484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods for preparing purified daptomycin'
[patent_app_type] => new
[patent_app_number] => 10/024701
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9297
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045484.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024701 | Methods for preparing purified daptomycin | Dec 16, 2001 | Abandoned |
| 10/018099 | Process for deacylation of lipodepsipeptides | Dec 10, 2001 | Abandoned |
Array
(
[id] => 7122867
[patent_doc_number] => 20050014696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone'
[patent_app_type] => utility
[patent_app_number] => 10/492908
[patent_app_country] => US
[patent_app_date] => 2001-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1291
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492908 | Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone | Nov 28, 2001 | Issued |
| 09/807354 | Inhibition of oncogene transcription by synthetic polyamides | Nov 20, 2001 | Abandoned |
| 09/979486 | Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1) | Nov 18, 2001 | Abandoned |
Array
(
[id] => 456627
[patent_doc_number] => 07244711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Association of calpain inhibitors and reactive oxygen species trapping agents'
[patent_app_type] => utility
[patent_app_number] => 10/415638
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415638 | Association of calpain inhibitors and reactive oxygen species trapping agents | Nov 13, 2001 | Issued |
Array
(
[id] => 6874148
[patent_doc_number] => 20030194445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Compositions and methods of use of peptides in combination with biocides and/or germicides'
[patent_app_type] => new
[patent_app_number] => 10/005931
[patent_app_country] => US
[patent_app_date] => 2001-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21254
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005931 | Compositions and methods of use of peptides in combination with biocides and/or germicides | Nov 11, 2001 | Abandoned |
Array
(
[id] => 7208877
[patent_doc_number] => 20040087765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Peptides, the production and use thereof for binding immunoglobulins'
[patent_app_type] => new
[patent_app_number] => 10/415665
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6345
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415665 | Peptides, the production and use thereof for binding immunoglobulins | Nov 7, 2001 | Issued |
Array
(
[id] => 7168808
[patent_doc_number] => 20040077550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Process for preparing distamycin derivatives'
[patent_app_type] => new
[patent_app_number] => 10/415091
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3358
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415091 | Process for preparing distamycin derivatives | Nov 6, 2001 | Issued |
Array
(
[id] => 686810
[patent_doc_number] => 07078380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements'
[patent_app_type] => utility
[patent_app_number] => 10/415935
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12291
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415935 | Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements | Nov 1, 2001 | Issued |
Array
(
[id] => 6721299
[patent_doc_number] => 20030054988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/999457
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3954
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054988.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999457
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999457 | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors | Oct 30, 2001 | Abandoned |
Array
(
[id] => 7156590
[patent_doc_number] => 20050026994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Use of 2, 4diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/035301
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9841
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035301 | Use of 2, 4diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors | Oct 24, 2001 | Abandoned |
Array
(
[id] => 737904
[patent_doc_number] => 07034109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Intracellular delivery of biological effectors'
[patent_app_type] => utility
[patent_app_number] => 10/399127
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399127 | Intracellular delivery of biological effectors | Oct 14, 2001 | Issued |
Array
(
[id] => 6552073
[patent_doc_number] => 20020111291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic\'s risk of developing complications and determining the efficacy of therapeutic intervention'
[patent_app_type] => new
[patent_app_number] => 09/974323
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17059
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111291.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974323
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974323 | Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteins | Oct 9, 2001 | Issued |